Sabinsa
Shoden ashwagandha (35% withanolides) — clinical validation, US patents, GRAS.
- Country
- India
in
shoden
gras
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ | ✓ |
| wood-construction | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Adaptogens and legal entheogens (nutraceutical market) | food-alt-protein | Medium | → |
| Forest biopharma & phytochemicals | wood-construction | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.